Hyrimoz 40 mg solution for injection in pre-filled syringe

Licence status
Authorised: 26/07/2018
Active substances
Adalimumab
Dosage Form
Solution for injection in pre-filled syringe
Licence number
EU/1/18/1286/001-003
Licence holder
Sandoz GmbH

Product documents

Licence information

ATC code
L04AB Tumor necrosis factor alpha (TNF-) inhibitors, L04AB04 adalimumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/07/2018